Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004378 · ClinicalTrials.gov registry record · NA
Stem Cell Transplantation (SCT) for Genetic Diseases
A NA study of Thrombocytopenia and Inborn Errors of Metabolism, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- NA
- Development phase
- 1
- Study location
NCT00004378 is a NA study of Thrombocytopenia and Inborn Errors of Metabolism that has completed, run by National Center for Research Resources (NCRR). The trial reports 1 study location across 1 state.
The verdict
NCT00004378, a NA study of Thrombocytopenia and Inborn Errors of Metabolism, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- NA
- Development phase
- 1
- Study location
Study Summary
OBJECTIVES: I. Ascertain whether stem cell transplantation (SCT) is an effective method by which missing or dysfunctional enzymes can be replaced in patients with various inborn errors of metabolism. II. Determine whether clinical manifestations of the specific disease may be arrested or reversed by this treatment.
Conditions Studied
Interventions
- PROCEDURE Stem Cell Transplantation
Study Locations (1)
California
- University of California Los Angeles Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Start Date | 1995-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004378
The ClinicalTrials.gov registry entry for NCT00004378 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Thrombocytopenia appearing as the primary indexed condition, and to 1 intervention - of which Stem Cell Transplantation is the first listed.
NCT00004378 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00004378 about?
NCT00004378 is a clinical study titled "Stem Cell Transplantation (SCT) for Genetic Diseases". OBJECTIVES: I. Ascertain whether stem cell transplantation (SCT) is an effective method by which missing or dysfunctional enzymes can be replaced in patients with various inborn errors of metabolism. II. Determine whether clinical manifestations of the specific disease may be arrested or reversed b...
What is the current status of trial NCT00004378?
This trial is currently completed. It is a NA study. The study started on 1995-01.
What conditions does trial NCT00004378 study?
This clinical trial studies the following conditions: Thrombocytopenia, Inborn Errors of Metabolism, Thalassemia Major, Metachromatic Leukodystrophy, Fanconi's Anemia.
What interventions are being tested in trial NCT00004378?
The interventions under investigation include: Stem Cell Transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT00004378?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00004378 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thrombocytopenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Platelet-Directed Whole Blood Transfusion Strategy for Malaria
RECRUITING · NA
-
Neonatal Platelet Transfusion Threshold Trial
RECRUITING · NA
-
Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury
RECRUITING · NA
-
Effects of a Platelet Transfusion Best Practices Alert
COMPLETED · NA
-
Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence
COMPLETED · NA
-
177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.